Shareholders meeting

Ref: ADL/SE/2026-27/45 September 26, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Sub: Proceedings of 41st Annual General Meeting Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Please find enclosed herewith proceedings of 41st Annual General Meeting ("AGM") of the Company held today i.e., Saturday, September 26, 2026 at 11:00 A.M. through Video Conferencing & Other Audio-Visual Means. Kindly take the same on record. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932 Proceedings of 41 Annual General Meeting (AGM) of Aarti Drugs Limited The 41st Annual General Meeting was held on Saturday, September 26, 2026 at 11:00 AM through Video Conferencing and Other Audio Visual Means in Compliance with the circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India. 93 members attended the meeting through Video Conferencing. Welcoming the Shareholders, Board members and invitees, the Company Secretary stated about the presence of; • Shri Chandrakant V. Gogri, Chairman Emeritus of the Company • Shri Prakash M. Patil, Chairman, Managing Director & CEO of the Company, • The Board Members, • Shri Ankit Paleja, Chairman of Stakeholders’ Relationship Committee, • Shri Hasmukh Dedhia, Chairman of Audit Committee, • Smt Neha Gada, Chairperson of Nomination & Remuneration Committee, • Representative of the Statutory Auditors, Secretarial Auditors and Scrutinizers. He further confirmed that the requisite quorum is present to commence with the proceedings of the meeting. He also stated that the requisite Statutory Registers and Records were made available for inspection by the members electronically. Then he requested to Chairman to call the meeting to order. Shri Prakash M. Patil, Chairman of the Company welcomed all the Members, Directors, Auditors and representatives present for the meeting and called the meeting to order. The Chairman stated that the Notice of the AGM dated August 27, 2026 and the copy of Annual Report for the financial year ended March 31, 2026 has already been circulated to the members of the Company electronically. With the permission of all it was taken as read. Then he requested Shri Adhish P. Patil, Chief Financial Officer to introduce the Board Members present. After the formal introduction of Board Members, Chief Financial Officer requested to the Chairman to begin with formal address to the members. Thereafter, the Chairman addressed the members of the Company with a brief speech wherein he updated the Company’s performance highlights, Major milestone during the year, Company’s objectives towards sustainability, Leadership transition, etc. Then, Chief Financial Officer gave a brief presentation on the Company which includes overview of the Company, Company’s performance for the year ended March 31, 2026, Financial highlights for the quarter ended June 30, 2026, etc. The Chairman then, after expressing gratitude to all the stakeholders, requested Company Secretary to take the proceedings forward. The Company Secretary stated that the facility for remote e-voting on all the resolutions as set out in the Notice of the AGM had been provided to the shareholders in proportion to their voting rights as on the cut-off date of Saturday, September, 19 2026. The e-voting period commenced at 09:00 AM on Wednesday, September 23, 2026 and concluded at 05:00 PM on Friday, September 25, 2026. He also informed that voting by electronic means was also available during the AGM to those shareholders who had not already voted by means of remote e-voting. The following items as stated in the Notice of 41st AGM were then taken up for consideration: Item Resolutions Ordinary Business 1 To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors’ and the Auditors thereon. 2 Approval to the Retirement of Shri Uday M. Patil (DIN: 01186406) who retires by rotation and has not offered himself for re-appointment as a Director of the Company. Special Business 3 Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Director of the Company. 4 Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Whole-time Director of the Company. 5 Appointment of Shri Adhish Prakash Patil (DIN: 02629496) as the Director of the Company. 6 Appointment of Shri Adhish Prakash Patil (DIN: 02629496) as the Managing Director of the Company. 7 Re-appointment of Shri Harshit Manilal Savla (DIN: 00005340) as the Joint Managing Director of the Company. 8 Re-appointment of Shri Harit Pragji Shah (DIN: 00005501) as the Whole- time Director of the Company. 9 Re-appointment of Shri Hasmukh Bhavanji Dedhia (DIN: 07510925) as an Independent Director of the Company for the second term of 5 (five) years. 10 Re-appointment of Shri Sandeep Madhusudan Joshi (DIN: 00516409) as an Independent Director of the Company for the second term of 5 (five) years. 11 Re-appointment of Shri Ajit Eledath Venugopalan (DIN: 09439069) as an Independent Director of the Company for the second term of 5 (five) years. 12 Approval to Shri Prakash Moreshwar Patil, a Related Party, to hold an Office or Place of Profit in the Company. 13 Payment of Profit Related Commission to the Non-executive Directors. 14 Aarti Drugs Limited Performance Stock Option Plan 2026’ (‘PSOP 2026’). 15 Grant of stock options under “Aarti Drugs Limited Performance Stock Option Plan 2026” (‘PSOP 2026’) to the Employees of the Subsidiary Companies, Group Companies and Associate Companies (Present or Future). 16 Ratification of remuneration of Cost Auditors for FY 2026-27. The Company Secretary thereafter invited the shareholders to put forth their views/ questions, if any relating to the Annual Financial Statements, for the year ended March 31, 2026 and matters related thereto. Some of the shareholders, attending the meeting through Video-Conferencing means, expressed their views / questions relating to the business and operations of the Company. After hearing from the speaker shareholders as above, Chief Financial Officer, responded to their questions. The Company Secretary thereafter requested to those shareholders who had not already voted by means of remote e-voting to vote. He mentioned that e-voting remain open for next 30 minutes after the conclusion of AGM. The Company Secretary then informed that the Company had appointed CS Monali Bhandari, Practicing Company Secretary and failing him CS Jagdish Patel, Practicing Company Secretary as a Scrutinizer to scrutinize the remote e-voting and e-voting process in fair and transparent manner. The results of the remote e-voting and e-voting at the 41st AGM will be declared within 2 working days of the conclusion of the AGM upon receipt of the Scrutinizer’s Report. The same shall be posted on the Company’s website www.aartidrugs.com , on the website of NSDL and communicated to the Stock Exchanges viz. BSE Limited and National Stock Exchange of India Limited. Since all the businesses mentioned in the Notice of the AGM were transacted, the Chairman thanked all the members for participating in the 41st Annual General Meeting of the Company and declared the meeting as concluded at 11:57 AM, further the window for voting was kept open for 30 minutes for e-voting. FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932